Subscribe / Renew |
|
Contact Us |
|
► Subscribe to our Free Weekly Newsletter |
home | Welcome, sign in or click here to subscribe. | login |
FEATURED NOTICE | |
Port of Bremerton Airport Feasibility Study | |
New Bid Calls | 9 |
New Consultant Notices | 3 |
New Supply Bids | 0 |
WILBURTON INSTRUCTIONAL SERVICE CENTER BELLEVUE SCHOOL DISTRICT Kassel & Associates |
HOWARD A. HANSON DAM ADDITIONAL WATER STORAGE PROJECT – FISH PASSAGE SOLICITATION NO: W912DW24R0004 Kiewit Infrastructure West Co. |
RESERVOIR 3 REPLACEMENT, PHASE 1 Walsh Construction Company II, LLC |
CITY HALL ADDITION & MODERNIZATION - CITY OF BUCKLEY Kassel & Associates |
POST IAF AIRLINE REALIGNMENT, MC/ CM BID PACKAGE #1 (CONTROLS, INSULATION) Shinn Mechanical Inc. |
more » |
print email to a friend reprints add to mydjc |
November 8, 2019
Bothell-based Seattle Genetics inked a licensing deal worth up to $160 million with BeiGene for an advanced preclinical cancer drug. The agent uses a proprietary Seattle Genetics antibody-based technology and is expected to advance into clinical trials in the first half of 2020. Seattle Genetics will develop it in the Americas, Europe and Japan while BeiGene will have Asia and the rest of the world. Beijing-based BeiGene focuses on cancer therapeutics.
MyDJC | Business | Construction | Real Estate | Architecture & Engineering | Environment | Machinery | Technology | Weekend
Copyright 2024 Seattle Daily Journal of Commerce | Terms of Service | Privacy Policy | Contact Us | Advertising | Site Index